Product NDC: | 13537-310 |
Proprietary Name: | ESIKA |
Non Proprietary Name: | Octinoxate and Oxybenzone |
Active Ingredient(s): | .05; .02 mg/mL; mg/mL & nbsp; Octinoxate and Oxybenzone |
Administration Route(s): | TOPICAL |
Dosage Form(s): | LOTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 13537-310 |
Labeler Name: | Ventura Corporation (San Juan, P.R) |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part352 |
Marketing Category: | OTC MONOGRAPH NOT FINAL |
Start Marketing Date: | 20110517 |
Package NDC: | 13537-310-02 |
Package Description: | 1 BOTTLE in 1 BOX (13537-310-02) > 30 mL in 1 BOTTLE (13537-310-01) |
NDC Code | 13537-310-02 |
Proprietary Name | ESIKA |
Package Description | 1 BOTTLE in 1 BOX (13537-310-02) > 30 mL in 1 BOTTLE (13537-310-01) |
Product NDC | 13537-310 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Octinoxate and Oxybenzone |
Dosage Form Name | LOTION |
Route Name | TOPICAL |
Start Marketing Date | 20110517 |
Marketing Category Name | OTC MONOGRAPH NOT FINAL |
Labeler Name | Ventura Corporation (San Juan, P.R) |
Substance Name | OCTINOXATE; OXYBENZONE |
Strength Number | .05; .02 |
Strength Unit | mg/mL; mg/mL |
Pharmaceutical Classes |